Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Koomen

Showing results (191-200 of 229) with videos related to

Pageof 23
Sort By:
Cancer|April 12, 2023
Dose-escalation trial of combination dabrafenib, trametinib, and AT13387 in patients with BRAF-mutant solid tumorsMeghan J Mooradian, James M Cleary, Anita Giobbie-Hurder, et al.
Science Signaling|August 16, 2022
IGF-binding proteins secreted by cancer-associated fibroblasts induce context-dependent drug sensitization of lung cancer cellsLily L Remsing Rix, Natalia J Sumi, Qianqian Hu, et al.
Nature Communications|November 29, 2023
HDAC8-mediated inhibition of EP300 drives a transcriptional state that increases melanoma brain metastasisMichael F Emmons, Richard L Bennett, Alberto Riva, et al.
Molecular Cancer Research : MCR|October 26, 2018
<i>PTPN11</i> Plays Oncogenic Roles and Is a Therapeutic Target for <i>BRAF</i> Wild-Type MelanomasKristen S Hill, Evan R Roberts, Xue Wang, et al.
Oncogene|June 16, 2015
Fibronectin induction abrogates the BRAF inhibitor response of BRAF V600E/PTEN-null melanoma cellsI V Fedorenko, E V Abel, J M Koomen, et al.
Molecular Cancer Research : MCR|January 13, 2022
Integrated Proteomics-Based Physical and Functional Mapping of AXL Kinase Signaling Pathways and Inhibitors Define Its Role in Cell MigrationAnurima Majumder, Sina Hosseinian, Mia Stroud, et al.
Cancer Research|February 15, 2011
PTEN loss confers BRAF inhibitor resistance to melanoma cells through the suppression of BIM expressionKim H T Paraiso, Yun Xiang, Vito W Rebecca, et al.
Metabolomics : Official Journal of the Metabolomic Society|October 18, 2025
A machine learning framework for classifying lipids in untargeted metabolomics using mass-to-charge ratios and retention timesChristelle Colin-Leitzinger, Yonatan Ayalew Mekonnen, Isis Narvaez-Bandera, et al.
Clinical and Experimental Immunology|December 21, 2020
Reconnaissance of tumor immune microenvironment spatial heterogeneity in metastatic renal cell carcinoma and correlation with immunotherapy responseA Hajiran, N Chakiryan, A M Aydin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 5, 2022
Single-cell Characterization of the Cellular Landscape of Acral Melanoma Identifies Novel Targets for ImmunotherapyJiannong Li, Inna Smalley, Zhihua Chen, et al.
Pageof 23

Showing results (191-200 of 229) with videos related to

Sort By:
Pageof 23
Cancer|April 12, 2023
Dose-escalation trial of combination dabrafenib, trametinib, and AT13387 in patients with BRAF-mutant solid tumorsMeghan J Mooradian, James M Cleary, Anita Giobbie-Hurder, et al.
Science Signaling|August 16, 2022
IGF-binding proteins secreted by cancer-associated fibroblasts induce context-dependent drug sensitization of lung cancer cellsLily L Remsing Rix, Natalia J Sumi, Qianqian Hu, et al.
Nature Communications|November 29, 2023
HDAC8-mediated inhibition of EP300 drives a transcriptional state that increases melanoma brain metastasisMichael F Emmons, Richard L Bennett, Alberto Riva, et al.
Molecular Cancer Research : MCR|October 26, 2018
<i>PTPN11</i> Plays Oncogenic Roles and Is a Therapeutic Target for <i>BRAF</i> Wild-Type MelanomasKristen S Hill, Evan R Roberts, Xue Wang, et al.
Oncogene|June 16, 2015
Fibronectin induction abrogates the BRAF inhibitor response of BRAF V600E/PTEN-null melanoma cellsI V Fedorenko, E V Abel, J M Koomen, et al.
Molecular Cancer Research : MCR|January 13, 2022
Integrated Proteomics-Based Physical and Functional Mapping of AXL Kinase Signaling Pathways and Inhibitors Define Its Role in Cell MigrationAnurima Majumder, Sina Hosseinian, Mia Stroud, et al.
Cancer Research|February 15, 2011
PTEN loss confers BRAF inhibitor resistance to melanoma cells through the suppression of BIM expressionKim H T Paraiso, Yun Xiang, Vito W Rebecca, et al.
Metabolomics : Official Journal of the Metabolomic Society|October 18, 2025
A machine learning framework for classifying lipids in untargeted metabolomics using mass-to-charge ratios and retention timesChristelle Colin-Leitzinger, Yonatan Ayalew Mekonnen, Isis Narvaez-Bandera, et al.
Clinical and Experimental Immunology|December 21, 2020
Reconnaissance of tumor immune microenvironment spatial heterogeneity in metastatic renal cell carcinoma and correlation with immunotherapy responseA Hajiran, N Chakiryan, A M Aydin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 5, 2022
Single-cell Characterization of the Cellular Landscape of Acral Melanoma Identifies Novel Targets for ImmunotherapyJiannong Li, Inna Smalley, Zhihua Chen, et al.
Pageof 23